Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONKEY VAX post-exposure monkeypox vaccination cohort
2022-002352-39Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of JYNNEOS in mpox, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Post-exposure vaccination failure within 28 days. Started Jun 2022; status: completed.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on 2022-002352-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002352-39.